1174894

Fresenius Kabi USA LLC — FEI 1450022

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 30, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Melrose Park, IL (United States)